Early research (Phase 1)Study completedNCT01358162
What this trial is testing
Phase IC Study of Safety and PK of SQ109 300mg Daily
Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Showing 20 of 0 results